Organizations: The Aurum Institute, SA; Vanderbilt University Medical Centre, USA; Health Economics and Epidemiology Research Office (HE²RO)
Study objective: To describe perceptions of behavioural facilitators and barriers to successful treatment of Rifampicin-Resistant tuberculosis (RR-TB) in Gauteng Province, South Africa among people with RR-TB and healthcare providers at DR-TB treatment facilities.
Evaluation description: An exploratory study using a survey, focus group discussions (FGDs) and in-depth interviews (IDIs) to generate behavioural insights from adult RR-TB care recipients and healthcare providers at DR-TB sites.
Study outcomes:
- Generate/ verify insights regarding healthcare provider and recipient of care experiences and journeys in the RR-TB care cascade
- Contexualise potential barriers, enablers and motivating factors to treatment completion
Study site: Selected DR-TB treatment facilities in Gauteng
Target population:
People initiated on RR-TB treatment
Healthcare providers giving care to RR-TB care recipients
Sample size & analysis:
- 10 healthcare providers
- 20 care recipients
Thematic analysis will be conducted to develop codes and identify themes. Design thinking tools will be used to map findings.
Duration: 6 months
